نتایج جستجو برای: hiv fusion inhibitors

تعداد نتایج: 504964  

Journal: :Bioorganic & medicinal chemistry 2008
Hiroki Nishikawa Shinya Oishi Mizuno Fujita Kentaro Watanabe Rei Tokiwa Hiroaki Ohno Eiichi Kodama Kazuki Izumi Keiko Kajiwara Takeshi Naitoh Masao Matsuoka Akira Otaka Nobutaka Fujii

Emergence of multi-drug resistant HIV-1 is a serious problem for AIDS treatment. Recently, the virus-cell membrane fusion process has been identified as a promising target for the development of novel drugs against these resistant variants. In this study, we identified a 29-residue peptide fusion inhibitor, SC29EK, which shows activity comparable to the previously reported inhibitor SC35EK. Som...

Journal: :The Journal of antimicrobial chemotherapy 2004
J K Rockstroh S Mauss

The number of antiretroviral-experienced HIV patients with multiple resistances against the currently available antiretroviral drug classes is increasing substantially. Therapeutic options for this specific group of patients are limited. The fusion inhibitor enfuvirtide represents the first new therapeutic option from a new drug class for this patient population. An optimized background therapy...

2012
Wataru Nomura Chie Hashimoto Hirokazu Tamamura

Journal: :The Journal of antibiotics 2001
H Chiba S Asanuma M Okamoto J Inokoshi H Tanaka K Fujita S Omura

The first step in cellular entry of HIV involves binding of the viral envelope glycoprotein complex (gp120/gp41) to specific receptor molecules on the target cells. The cell-cell fusion (syncytium formation) between env expressing cells and CD4+ cells mimics the viral infection of the host cells. To search for anti-HIV substances preventing this process, we constructed the recombinant cell line...

Journal: :Virology 2015
Lin-Xu Wang Michael Mellon Dane Bowder Meghan Quinn Danielle Shea Charles Wood Shi-Hua Xiang

Human immunodeficiency virus type 1 (HIV-1) transmission and infection occur mainly via the mucosal surfaces. The commensal bacteria residing in these surfaces can potentially be employed as a vehicle for delivering inhibitors to prevent HIV-1 infection. In this study, we have employed a bacteria-based strategy to display a broadly neutralizing antibody VRC01, which could potentially be used to...

2012
Xiaoyi Wang Weiliang Xiong Xiaochu Ma Meili Wei Yanxia Chen Lu Lu Asim K. Debnath Shibo Jiang Chungen Pan

During the process of HIV-1 fusion with the target cell, the N-terminal heptad repeat (NHR) of gp41 interacts with the C-terminal heptad repeat (CHR) to form fusogenic six-helix bundle (6-HB) core. We previously identified a crucial residue for 6-HB formation and virus entry--Lys63 (K63) in the C-terminal region of NHR (aa 54-70), which forms a hydrophobic cavity. It can form an important salt ...

Some new diazo incorporated coumarin compounds were designed and synthesized to evaluate their anti-HIV activity. Overall, compounds were active against HIV at 100 μM. Additionally, no cytotoxic effect was observed at this concentration. The compound with 4-chlorobenzyl group indicated the best anti-HIV activity (52%). Docking studies using the later crystallographic data available for PFV inte...

2010
Liangqun Huang Chaoping Chen

BACKGROUND HIV protease (PR) is a virus-encoded aspartic protease that is essential for viral replication and infectivity. The fully active and mature dimeric protease is released from the Gag-Pol polyprotein as a result of precursor autoprocessing. RESULTS We here describe a simple model system to directly examine HIV protease autoprocessing in transfected mammalian cells. A fusion precursor...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید